These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9150782)

  • 1. Magnesium--a profibrillatory or antifibrillatory drug depending on plasma concentration, heart rate and myocardial perfusion.
    Aupetit JF; Freysz M; Faucon G; Loufoua-Moundanga J; Coquelin H; Timour Q
    Acta Anaesthesiol Scand; 1997 Apr; 41(4):516-23. PubMed ID: 9150782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.
    Aupetit JF; Loufoua-Moundanga J; Faucon G; Timour Q
    Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
    Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
    Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.
    Bui-Xuan B; Aupetit JF; Freysz M; Faucon G; Timour Q
    Pharmacotherapy; 1997; 17(4):737-45. PubMed ID: 9250551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].
    Timour Q; Freysz M; Aupetit JF; Loufoua J; Frassati D; Faucon G
    Bull Acad Natl Med; 1996 Jan; 180(1):215-26; discussion 226-7. PubMed ID: 8696877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac beta-adrenoreceptor activation and ventricular fibrillation under normal and ischemic conditions.
    Bui-Xuan B; Aupetit JF; Freysz M; Loufoua J; Faucon G; Timour Q
    Cardiovasc Res; 1996 Dec; 32(6):1056-63. PubMed ID: 9035900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
    Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a beta-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia duration.
    Aupetit JF; Frassati D; Bui-Xuan B; Freysz M; Faucon G; Timour Q
    Cardiovasc Res; 1998 Mar; 37(3):646-55. PubMed ID: 9659448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Demonstration of the fibrillatory effect of class I anti-arrhythmia agents based on the time of fibrillation onset and electrical threshold in myocardial ischemia].
    Timour Q; Aupetit JF; Loufoua-Moundanga JL; Barral-Cadière L; Freysz M; Faucon G
    Therapie; 1994; 49(4):349-53. PubMed ID: 7878603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of asynchronous activation of the ventricular fibres by an ectopic pacemaker in the accidents, especially fibrillation, caused by Ic antiarrhythmic drugs.
    Timour Q; Aupetit JF; Loufoua-Moundanga J; Kioueh I; Omar S; Chevrel G; Faucon G
    Fundam Clin Pharmacol; 1992; 6(4-5):159-67. PubMed ID: 1427561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change of a beneficial effect into an untoward effect by ischaemia: effect of quinidine-like drugs on vulnerability to ventricular fibrillation.
    Aupetit JF; Freysz M; Faucon G; Loufoua J; Timour Q
    Environ Toxicol Pharmacol; 1996 Aug; 2(1):1-7. PubMed ID: 21781694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of magnesium on ischemic and reperfusion arrhythmias in a canine model with diminished collateral blood flow.
    Euler DE
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):565-71. PubMed ID: 8547206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ.
    Timour Q; Aupetit JF; Loufoua-Moundanga J; Gerentes-Chassagne I; Kioueh I; Faucon G
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):645-51. PubMed ID: 1944606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of the ischaemia-induced fall of electrical ventricular fibrillation threshold by a calcium antagonist, diltiazem.
    Aupetit JF; Timour Q; Chevrel G; Loufoua-Moundanga J; Omar S; Faucon G
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):509-14. PubMed ID: 8114951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart.
    Aupetit JF; Timour Q; Larbre JP; Loufoua-Moundanga J; Kioueh I; Lopez M; Faucon G
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):217-23. PubMed ID: 8357775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel modulators and susceptibility to ischaemic ventricular fibrillation: modification of cellular calcium overload.
    Timour Q; Larbre JP; Kioueh I; Aupetit JF; Loufoua-Moundanga J; Vialle A; Faucon G
    Arch Int Pharmacodyn Ther; 1992; 315():30-46. PubMed ID: 1384452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists and prevention of ventricular fibrillation induced by transient or persistent ischemia.
    Timour Q; Bui-Xuan B; Aupetit JF; Freysz M; Evreux JC; Faucon G
    Jpn Heart J; 1997 Mar; 38(2):237-51. PubMed ID: 9201111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dofetilide reduces the incidence of ventricular fibrillation during acute myocardial ischaemia. A randomised study in pigs.
    Andersen HR; Wiggers H; Knudsen LL; Simonsen I; Thomsen PE; Christiansen N
    Cardiovasc Res; 1994 Nov; 28(11):1635-40. PubMed ID: 7842456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of different classes of anti-arrhythmia agents on the vulnerability of ischemic ventricular fibrillation].
    Aupetit JF; Timour Q; Chevrel G; Omar S; Loufoua-Moundanga J; Faucon G
    Therapie; 1993; 48(4):403-7. PubMed ID: 8128424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate reduction with ivabradine increases ischaemia-induced ventricular fibrillation threshold: role of myocyte structure and myocardial perfusion.
    Vaillant F; Dehina L; Mazzadi A; Descotes J; Chevalier P; Tabib A; Bui-Xuan B; Riera C; Belhani D; Timour Q
    Resuscitation; 2011 Aug; 82(8):1092-9. PubMed ID: 21561702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.